SCHEMBL762899

SCHEMBL762899

CCc1ccc(-c2nnc(-c3ccccc3)o2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.65
RAB9A P51151 14/20 0.65
SMN1; SMN2 Q16637 8/20 0.65
MAPT P10636 2/20 0.63
HPGD P15428 7/20 0.63
POLB P06746 1/20 0.63
NFKB1 P19838 1/20 0.63
NFKB2 Q00653 1/20 0.63
RELA Q04206 1/20 0.63
ALDH1A1 P00352 3/20 0.62
KDM4E B2RXH2 2/20 0.62
TP53 P04637 1/20 0.62
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
HSD17B10 Q99714 2/20 0.56
GLA P06280 1/20 0.56
ALOX15 P16050 1/20 0.56
ATAD2 Q6PL18 1/20 0.55
TSHR P16473 4/20 0.53
GPR55 Q9Y2T6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10062469 0.92 NOTUM (0.55) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL13427019 0.85 RAB9A (0.51) NPC1RAB9ASMN1; SMN2MAPTHPGD
Butane SCHEMBL3452678 0.84 NPC1 (0.71) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL4343181 0.83 NPC1 (0.94) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL27721644 0.83 NPC1 (0.70) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL10076951 0.82 RAB9A (0.68) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL8023035 0.82 HSD11B1 (0.62) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL13359027 0.82 NPC1 (0.48) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL21698291 0.81 HSD11B1 (0.60) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL12171111 0.81 NPC1 (0.68) NPC1RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633582-B2 Compositions, optical component, system including an optical component, and other products SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-28 US disclosed
US-20170283692-A1 COMPOSTITIONS, OPTICAL COMPONENT, SYSTEM INCLUDING AN OPTICAL COMPONENT, AND OTHER PRODUCTS SAMSUNG ELECTRONICS CO LTD (KR) 2017-10-05 US disclosed
US-8138303-B2 Polymers BASF SE (DE) 2012-03-20 US disclosed
US-20100249349-A1 Novel Polymers UDC IRELAND LIMITED (IE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249349-A1 Novel Polymers OCIAD2, OCIAD1, SLCO4C1 NPC1 974/4885RAB9A 1601/4885SMN1; SMN2 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.